Patents by Inventor Baerbel LoSacco

Baerbel LoSacco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7951933
    Abstract: The invention provides for a substantially purified polypeptide referred to herein as CD38JL that is a CD38 splice variant comprised of the polypeptide of SEQ ID NO: 1 or a fragment thereof. The invention also provides methods for treating preventing and diagnosing disorders associated with expression of CD38JL.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: May 31, 2011
    Assignee: Boehringer Ingelheim Pharmaceutical, Inc.
    Inventors: Jun Li, Xiang Li, Baerbel LoSacco, Zhenhao Qi
  • Publication number: 20080089881
    Abstract: A method of determining whether a subject is suffering from or at risk for developing inflammatory diseases by determining the level of HM74 and/or HM74A in tissue damage. Also disclosed are a method of identifying a compound for treating inflammatory diseases, a method of treating inflammatory diseases, and a pharmaceutical composition or a packaged product for treating inflammatory diseases.
    Type: Application
    Filed: December 6, 2006
    Publication date: April 17, 2008
    Inventors: Jun Li, Xiang John Li, Baerbel Losacco
  • Publication number: 20050202482
    Abstract: The invention provides for a substantially purified polypeptide referred to herein as CD38JL that is a CD38 splice variant comprised of the polypeptide of SEQ ID NO: 1 or a fragment thereof. The invention also provides methods for treating preventing and diagnosing disorders associated with expression of CD38JL.
    Type: Application
    Filed: February 10, 2005
    Publication date: September 15, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Jun Li, Xiang Li, Baerbel LoSacco, Zhenhao Qi